Buprenorphine and Integrated HIV Care Evaluation

PHASE4UnknownINTERVENTIONAL
Enrollment

1,350

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

December 31, 2008

Conditions
Opioid-Related DisordersHIV InfectionsAIDS
Interventions
DRUG

Buprenorphine

BEHAVIORAL

Integrated HIV care and office-based opioid dependence treatment

Trial Locations (10)

10467

RECRUITING

Montefiore Medical Center, New York

21287

RECRUITING

Johns Hopkins University, Baltimore

33136

RECRUITING

University of Miami School of Medicine, Miami

60612

RECRUITING

The CORE Center, Chicago

85745

RECRUITING

El Rio Santa Cruz Neighborhood Health Center, Tucson

94110

RECRUITING

University of California San Francisco, San Francisco

94612

RECRUITING

Organization to Achieve Solutions in Substance Abuse, Oakland

97239

RECRUITING

Oregon Health & Science University, Portland

06510

RECRUITING

Yale University School of Medicine AIDS Program, New Haven

02903

RECRUITING

The Miriam Hospital, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Health Resources and Services Administration (HRSA)

FED

collaborator

El Rio Santa Cruz Neighborhood Health Center

UNKNOWN

collaborator

Organization to Achieve Solutions in Substance Abuse (OASIS)

OTHER

collaborator

Oregon Health and Science University

OTHER

collaborator

Montefiore Medical Center

OTHER

collaborator

University of Miami

OTHER

collaborator

Brown University

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

CORE Center, Cook County Bureau of Health Services

UNKNOWN

collaborator

Yale University

OTHER

lead

The New York Academy of Medicine

OTHER